CN Stock MarketDetailed Quotes

002424 Guizhou Bailing Group Pharmaceutical

Watchlist
  • 3.39
  • +0.02+0.59%
Not Open Jun 4 15:00 CST
4.78BMarket Cap-10495P/E (TTM)

Guizhou Bailing Group Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guizhou Bailing Group Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

1.33B

+22.09%
EPS(YoY)

0.04

-42.86%
Analyst Rating

Strong Buy

Jun 4, 2024

Guizhou Bailing Group Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 6.475B--
--2024/FY-- / 5.434B--
--2023/FY4.263B / 4.475B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 6.475B--
--2024/FY-- / 5.434B--
--2023/FY4.263B / 4.475B--

Guizhou Bailing Group Pharmaceutical Earnings Reports

  • Guizhou Bailing Group Pharmaceutical: 2024 First Quarter Report

    Apr 29 12:00 ET

  • Guizhou Bailing Group Pharmaceutical: 2023 Annual Report Summary

    Apr 29 12:00 ET

  • Guizhou Bailing Group Pharmaceutical: 2023 ANNUAL REPORT

    Apr 29 12:00 ET

  • Guizhou Bailing: Report for the third quarter of 2023

    Oct 26, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 4, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg